1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (ED-71) does not disturb fracture healing process in rat's femoral fracture model.

被引:0
|
作者
Mori, S [1 ]
Cao, Y [1 ]
Miyamoto, K [1 ]
Iwata, K [1 ]
Mahiba, T [1 ]
Akiyama, T [1 ]
Komatsubara, S [1 ]
Manabe, T [1 ]
Norimatsu, H [1 ]
机构
[1] Kagawa Univ, Fac Med, Kagawa, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S323 / S323
页数:1
相关论文
共 42 条
  • [21] Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-epi-1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3: 20-epi-ED-71]
    Hatakeyama, Susumi
    Yoshino, Madoka
    Eto, Kohei
    Takahashi, Keisuke
    Ishihara, Jun
    Ono, Yoshiyuki
    Saito, Hitoshi
    Kubodera, Noboru
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2010, 121 (1-2): : 25 - 28
  • [22] The determination of 2β-(3-hydroxypropoxy)-1α-,25-dihydroxy vitamin D3 (ED-71) in human serum by high-performance liquid chromatography-electrospray tandem mass spectrometry
    Murao, N
    Ohishi, N
    Nabuchi, Y
    Ishigai, M
    Kawanishi, T
    Aso, Y
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 823 (02): : 61 - 68
  • [23] Synthesis and biological characterization of 1α,24,25-trihydroxy-2β-(3-hydroxypropoxy)vitamin D3 (24-hydroxylated ED-71)
    Hatakeyama, S
    Kawase, A
    Uchiyama, Y
    Maeyama, J
    Iwabuchi, Y
    Kubodera, N
    STEROIDS, 2001, 66 (3-5) : 267 - 276
  • [24] 1a,25-dihydroxy-2b-(3-hydroxylpropoxy) vitamin D3 (ED-71) for the treatment of osteoporosis:: Characteristic of ED-71 as an anti-osteoporotic agent and synthesis of diastereomers of ED-71 at 1 and 3 positions
    Kubodera, N.
    Hatakeyama, S.
    ANTICANCER RESEARCH, 2008, 28 (3A) : 1620 - 1620
  • [25] History of the development of new vitamin D analogs:: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71)
    Nishii, Y
    Okano, T
    STEROIDS, 2001, 66 (3-5) : 137 - 146
  • [26] Synthesis of 1 alpha,3 beta-dihydroxy-2 beta-(3-hydroxypropoxy)-5,7-choladiene derivative and its application to the synthesis of 1 alpha,25-dihydroxy-2 beta-(3-hydroxypropoxy)vitamin D-3
    Tachibana, Y
    NIPPON KAGAKU KAISHI, 1996, (01) : 91 - 96
  • [27] A NEW VITAMIN-D(3) DERIVATIVE, 2-BETA-(3-HYDROXYPROPOXY)-1-ALPHA, 25(OH)2D3 (ED-71) RESTORES THE BONE MASS IN ESTABLISHED OSTEOPOROSIS IN RATS
    TSURUKAMI, H
    NAKAMURA, T
    YAMAURA, M
    NARUSAWA, K
    OHNISHI, H
    SUZUKI, K
    SATO, K
    NANJO, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 : S141 - S141
  • [28] Serum 1α,25-dihydroxyvitamin D3 accumulates into the fracture callus during rat femoral fracture healing
    Jingushi, S
    Iwaki, A
    Higuchi, O
    Azuma, Y
    Ohta, T
    Shida, JI
    Izumi, T
    Ikenoue, T
    Sugioka, Y
    Iwamoto, Y
    ENDOCRINOLOGY, 1998, 139 (04) : 1467 - 1473
  • [29] Synthesis and preliminary biological evaluation of 20-epi-eldecalcitol [20-Epi-1alfa,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3: 20-Epi-ED-71]
    Hatakeyama, Susumi
    Yoshino, Madoka
    Eto, Kohei Kohei
    Takahashi, Keisuke
    Ishihara, Jun
    Ono, Yoshiyuki
    Saito, Hitoshi
    Kubodera, Noboru
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [30] 2-BETA-(3-HYDROXYPROPOXY)-1-ALPHA,25-DIHYDROXYVITAMIN-D3 (ED-71), PREVENTIVE AND THERAPEUTIC EFFECTS ON BONE-MINERAL LOSS IN OVARIECTOMIZED RATS
    KOBAYASHI, T
    OKANO, T
    TSUGAWA, N
    MURANO, M
    MASUDA, S
    TAKEUCHI, A
    SATO, K
    NISHII, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1993, 3 (09) : 1815 - 1819